Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents

References

• AlgaziAPSoonCWDaudAITreatment of cutaneous melanoma: Current approaches and future prospectsCancer Manag Res2010219721121188111
   PubMedGoogle Scholar
• MouawadRSebertMMichelsJBlochJSpanoJPKhayatDTreatment for metastatic malignant melanoma: old drugs and new strategiesCrit Rev Oncol Hematol201074273919781957
   PubMed Web of Science ®Google Scholar
• JilaveanuLBAzizSAKlugerHMChemotherapy and biologic therapies for melanoma: Do they work?Clin Dermatol20092761462519880049
   PubMed Web of Science ®Google Scholar
• MacKeeGMCipollaroACMontgomeryHX-rays and Radium in the Treatment of Diseases of the Skin4th edPhiladelphia, PALea and Febiger1946
   Google Scholar
• MillionRRCassisiNJManagement of Head and Neck Cancer: A Multidisciplinary ApproachPhiladelphia, PALippincott1984
   Google Scholar
• JenretteJMMalignant melanoma: the role of radiation therapy revisitedSemin Oncol1996237597628970599
   PubMed Web of Science ®Google Scholar
• StevensGMcKayMJDispelling the myths surrounding radiotherapy for treatment of cutaneous melanomaLancet Oncol2006757558316814209
   PubMed Web of Science ®Google Scholar
• OvergaardJOvergaardMHansenPVvon der MaaseHSome factors of importance in the radiation treatment of malignant melanomaRadiother Oncol198651831923085169
   PubMed Web of Science ®Google Scholar
• RofstadEKRadiation biology of malignant melanomaActa Radiol Oncol1986251103010642
   PubMedGoogle Scholar
• KorcumAFSanliogluSAksuGTuncelNErinNRadiotherapy-induced decreases in substance P levels may potentiate melanoma growthMol Med Report2009231932621475832
   PubMed Web of Science ®Google Scholar
• HomerMJRiesLAGKrapchoMSEER Cancer Statistics Review, 1975–2006Bethseda, MDNational Cancer Institute2009 Available from: http://seer.cancer.gov/csr/1975_2006/Accessed April 3, 2010
   Google Scholar
• JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin J200959225249
   PubMed Web of Science ®Google Scholar
• BalchCMGershenwaldJESoongSJFinal version of 2009 AJCC melanoma staging and classificationJ Clin Oncol2009276199620619917835
   PubMed Web of Science ®Google Scholar
• RigelDSCarucciJAMalignant melanoma: Prevention, early detection, and treatment in the 21st centuryCA Cancer J Clin20005021523610986965
   PubMed Web of Science ®Google Scholar
• NetworkNCCNCCN Clinical Practice Guidelines in Oncology: Melanoma2010 Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed June 22, 2011
   Google Scholar
• KhayatDRixeOMartinGSurgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick)Cancer2003971941194612673721
   PubMed Web of Science ®Google Scholar
• BalchCMSoongSJSmithTLong-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1–4 mm melanomasAnn Surg Oncol2001810110811258773
   PubMed Web of Science ®Google Scholar
• VeronesiUCascinelliNNarrow excision (1-cm margin). A safe procedure for thin cutaneous melanomaArch Surg19911264384412009058
   PubMedGoogle Scholar
• VeronesiUCascinelliNAdamusJThin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cmN Engl J Med1988318115911623079582
   PubMed Web of Science ®Google Scholar
• ThomasJMNewton-BishopJA’HernRExcision margins in high-risk malignant melanomaN Engl J Med200435075776614973217
   PubMed Web of Science ®Google Scholar
• ColeyWBLeucutiaTThe treatment of metastatic tumors of the skin: pigmented moles and melanomasAJR Am J Roentgenol192411335336
   Google Scholar
• EllisFRadiosensitivity of malignant melanomataBr J Radiol193912327352
   Google Scholar
• HellriegelWRadiation therapy for primary and metastatic melanomaAnn N Y Acad Sci196310013114113953619
   PubMed Web of Science ®Google Scholar
• BarrancoSCRomsdahlMMHumphreyRMThe radiation response of human malignant melanoma cells grown in vitroCancer Res1971318308335088486
   PubMed Web of Science ®Google Scholar
• OvergaardJvon der MaaseHOvergaardMA randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanomaInt J Radiat Oncol Biol Phys198511183718394044346
   PubMed Web of Science ®Google Scholar
• SauseWTCooperJSRushSFraction size in external beam radiation therapy in the treatment of melanomaInt J Radiat Oncol Biol Phys1991204294321995527
   PubMed Web of Science ®Google Scholar
• BentzenSMOvergaardJThamesHDClinical radiobiology of malignant melanomaRadiother Oncol1989161691822587808
   PubMed Web of Science ®Google Scholar
• KonefalJBEmamiBPilepichMVMalignant melanoma: analysis of dose fractionation in radiation therapyRadiology19871646076103112864
   PubMed Web of Science ®Google Scholar
• AngKKByersRMPetersLJRegional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary resultsArch Otolaryngol Head Neck Surg19901161691722297407
   PubMedGoogle Scholar
• BurmeisterBHMark SmithersBBurmeisterEA prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06Radiother Oncol20068113614217064803
   PubMed Web of Science ®Google Scholar
• HendersonMABurmeisterBThompsonJFAdjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: results of an Intergroup randomized trial (ANZMTG 01.02/TROG 02.01)J Clin Oncol20092718 SupplAbstr LBA9084
   Web of Science ®Google Scholar
• SkibberJMSoongSJAustinLBalchCMSawayaRECranial irradiation after surgical excision of brain metastases in melanoma patientsAnn Surg Oncol199631181238646510
   PubMed Web of Science ®Google Scholar
• SampsonJHCarterJHJFriedmanAHSeiglerHFDemographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanomaJ Neurosurg19988811209420067
   PubMed Web of Science ®Google Scholar
• MoriYKondziolkaDFlickingerJCKirkwoodJMAgarwalaSLunsfordLDStereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survivalInt J Radiat Oncol Biol Phys1998425815899806518
   PubMed Web of Science ®Google Scholar
• SelekUChangELHassenbuschSJrStereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastasesInt J Radiat Oncol Biol Phys2004591097110615234044
   PubMed Web of Science ®Google Scholar
• YuCChenJCApuzzoMLMetastatic melanoma to the brain: prognostic factors after gamma knife radiosurgeryInt J Radiat Oncol Biol Phys2002521277128711955740
   PubMed Web of Science ®Google Scholar
• RadbillAEFiveashJFFalkenbergETInitial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicityCancer200410182583315305416
   PubMed Web of Science ®Google Scholar
• ScorsettiMFacoettiANavarriaPHypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastasesAnticancer Res2009294259426319846983
   PubMed Web of Science ®Google Scholar
• StoneACooperJKoenigKLGolfinosJGOratzRA comparison of survival rates for treatment of melanoma metastatic to the brainCancer Invest20042249249715565805
   PubMed Web of Science ®Google Scholar
• HerlynMNathansonKLTaking the guesswork out of uveal melanomaN Engl J Med20103632256225721083377
   PubMed Web of Science ®Google Scholar
• Van RaamsdonkJMMengYCampDDecreased energy metabolism extends life span in Caenorhabditis elegans without reducing oxidative damageGenetics201018555957120382831
   PubMed Web of Science ®Google Scholar
• Van RaamsdonkCDGriewankKGCrosbyMBMutations in GNA11 in uveal melanomaN Engl J Med20103632191219921083380
   PubMed Web of Science ®Google Scholar
• Diener-WestMEarleJDFineSLThe COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No. 18Arch Ophthalmol200111996998211448319
   PubMedGoogle Scholar
• TemamSMamelleGMarandasPPostoperative radiotherapy for primary mucosal melanoma of the head and neckCancer200510331331915578718
   PubMed Web of Science ®Google Scholar
• OwensJMRobertsDBMyersJNThe role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck regionArch Otolaryngol Head Neck Surg200312986486812925346
   PubMedGoogle Scholar
• CurtinJABusamKPinkelDBastianBCSomatic activation of KIT in distinct subtypes of melanomaJ Clin Oncol2006244340434616908931
   PubMed Web of Science ®Google Scholar
• HandoliasDHamiltonALSalemiRClinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KITBr J Cancer20101021219122320372153
   PubMed Web of Science ®Google Scholar
• MoncrieffMDMartinRO’BrienCJAdjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: Is there any benefit for high-risk patients?Ann Surg Oncol2008153022302718958539
   PubMed Web of Science ®Google Scholar
• BalloMTAngKKRadiotherapy for cutaneous malignant melanoma: Rationale and indicationsOncology (Williston Park)2004189910714768409
   PubMed Web of Science ®Google Scholar
• ChangDTAmdurRJMorrisCGMendenhallWMAdjuvant radiotherapy for cutaneous melanoma: Comparing hypofractionation to conventional fractionationInt J Radiat Oncol Biol Phys2006661051105516973303
   PubMed Web of Science ®Google Scholar
• VermaSQuirtIMcCreadyDBakKCharetteMIscoeNSystematic review of systemic adjuvant therapy for patients at high risk for recurrent melanomaCancer20061061431144216511841
   PubMed Web of Science ®Google Scholar
• AgrawalSKaneJM3rdGuadagnoloBAKraybillWGBalloMTThe benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanomaCancer20091155836584419701906
   PubMed Web of Science ®Google Scholar
• BalloMTRossMICormierJNCombined-modality therapy for patients with regional nodal metastases from melanomaInt J Radiat Oncol Biol Phys20066410611316182463
   PubMed Web of Science ®Google Scholar
• UongAZonLIMelanocytes in development and cancerJ Cell Physiol2010222384119795394
   PubMed Web of Science ®Google Scholar
• MillerAJMihmMCJrMelanomaN Engl J Med2006355516516822996
   PubMed Web of Science ®Google Scholar
• SatyamoorthyKChehabNHWatermanMJAberrant regulation and function of wild-type p53 in radioresistant melanoma cellsCell Growth Differ20001146747411007451
   PubMedGoogle Scholar
• CrosbyMEAlmasanAOpposing roles of E2Fs in cell proliferation and deathCancer Biol Ther200431208121115662116
   PubMed Web of Science ®Google Scholar
• AlmasanAYinYKellyREDeficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosisProc Natl Acad Sci U S A199592543654407777526
   PubMed Web of Science ®Google Scholar
• MazumderSDuPreeELAlmasanAA dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapyCurr Cancer Drug Targets20044657514965268
   PubMed Web of Science ®Google Scholar
• FecherLACummingsSDKeefeMJAlaniRMToward a molecular classification of melanomaJ Clin Oncol2007251606162017443002
   PubMed Web of Science ®Google Scholar
• NogueiraCKimKHSungHCooperative interactions of PTEN deficiency and RAS activation in melanoma metastasisOncogene2010296222623220711233
   PubMed Web of Science ®Google Scholar
• HaferkampSBeckerTMScurrLLKeffordRFRizosHp16INK 4a-induced senescence is disabled by melanoma-associated mutationsAging Cell2008773374518843795
   PubMed Web of Science ®Google Scholar
• JohnsonSMTorriceCDBellJFMitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibitionJ Clin Invest20101202528253620577054
   PubMed Web of Science ®Google Scholar
• TsaiJLeeJTWangWDiscovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProc Natl Acad Sci U S A20081053041304618287029
   PubMed Web of Science ®Google Scholar
• FlahertyKTPuzanovIKimKBInhibition of mutated, activated BRAF in metastatic melanomaN Engl J Med201036380981920818844
   PubMed Web of Science ®Google Scholar
• GudkovAVKomarovaEARadioprotection: smart games with deathJ Clin Invest20101202270227320577043
   PubMed Web of Science ®Google Scholar
• YangJSplittgerberRYullFEConditional ablation of Ikkb inhibits melanoma tumor development in miceJ Clin Invest20101202563257420530876
   PubMed Web of Science ®Google Scholar
• JohnsonGEIvanovVNHeiTKRadiosensitization of melanoma cells through combined inhibition of protein regulators of cell survivalApoptosis20081379080218454317
   PubMed Web of Science ®Google Scholar
• MatsumuraYYamagishiNMiyakoshiJImamuraSTakebeHIncrease in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 geneCancer Lett199711591969097983
   PubMed Web of Science ®Google Scholar
• HodiFSO’DaySJMcDermottDFImproved survival with ipilimumab in patients with metastatic melanomaN Engl J Med201036371172320525992
   PubMed Web of Science ®Google Scholar
• KaminskiJMShinoharaESummersJBNiermannKJMorimotoABrousalJThe controversial abscopal effectCancer Treat Rev20053115917215923088
   PubMed Web of Science ®Google Scholar
• AsciertoPAStreicherHZSznolMMelanoma: A model for testing new agents in combination therapiesJ Transl Med201083820406483
   PubMed Web of Science ®Google Scholar
• SchildSEBehlDMarkovicSNBrain metastases from melanoma: Is there a role for concurrent temozolomide in addition to whole brain radiation therapy?Am J Clin Oncol20103363363620042969
   PubMed Web of Science ®Google Scholar
• GrayRJPockajBAKirkwoodJMAn update on adjuvant interferon for melanomaCancer Control20029162111907462
   PubMedGoogle Scholar
• LiuYJIPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursorsAnnu Rev Immunol20052327530615771572
   PubMed Web of Science ®Google Scholar
• TakaokaAHayakawaSYanaiHIntegration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defenceNature200342451652312872134
   PubMed Web of Science ®Google Scholar
• CascinelliNBelliFMacKieRMSantinamiMBufalinoRMorabitoAEffect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trialLancet200135886686911567700
   PubMed Web of Science ®Google Scholar
• HancockBWWheatleyKHarrisSAdjuvant interferon in high-risk melanoma: The AIM HIGH Study – United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon alfa-2a in high-risk resected malignant melanomaJ Clin Oncol200422536114665609
   PubMed Web of Science ®Google Scholar
• KirkwoodJMStrawdermanMHErnstoffMSSmithTJBordenECBlumRHInterferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684J Clin Oncol1996147178558223
   PubMed Web of Science ®Google Scholar
• KirkwoodJMIbrahimJGSondakVKHigh- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup trial E1690/S9111/C9190J Clin Oncol2000182444245810856105
   PubMed Web of Science ®Google Scholar
• NguyenNPSallahSChildressCSalehpourMRKarlssonUInterferon- alpha combined with radiotherapy in the treatment of unresectable melanomaCancer Invest20011926126511338883
   PubMed Web of Science ®Google Scholar
• GyorkiDEAinslieJJoonMLHendersonMAMillwardMMcArthurGAConcurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma – a retrospective single centre studyMelanoma Res20041422323015179193
   PubMed Web of Science ®Google Scholar
• ConillCJorcanoSDomingo-DomenechJToxicity of combined treatment of adjuvant irradiation and interferon alpha2b in high-risk melanoma patientsMelanoma Res20071730430917885585
   PubMed Web of Science ®Google Scholar
• HazardLJSauseWTNoyesRDCombined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: the potential for increased radiation toxicityInt J Radiat Oncol Biol Phys20025279680011849803
   PubMed Web of Science ®Google Scholar
• PaulEMullerIRennerHBodekerRHCochranAJTreatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injectionMelanoma Res20031361161714646625
   PubMed Web of Science ®Google Scholar
• MansfieldASMarkovicSNNovel therapeutics for the treatment of metastatic melanomaFuture Oncol2009554355719450181
   PubMed Web of Science ®Google Scholar
• LugadeAASorensenEWGerberSAMoranJPFrelingerJGLordEMRadiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunityJ Immunol20081803132313918292536
   PubMed Web of Science ®Google Scholar
• LeUMKaurinDGSloatBRYanasarnNCuiZLocalized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activityRadiother Oncol20099027327919013656
   PubMed Web of Science ®Google Scholar
• KhanAJWallBAAhlawatSRiluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivoClin Cancer Res2011171807181421325066
   PubMed Web of Science ®Google Scholar